dr. ing. J.K. (Jo ) Groenendaal

dr. ing. J.K. (Jo ) Groenendaal

Associate Professor

Show full profile

Research Output (71)

Characterization of gastrin-cholecystokinin 2 receptor interaction in relation to c-fos induction.

Hollestelle M.J., Timmerman P., Meloen R.H., Höppener J.W.M. 2008, In: Endocrine-Related Cancer. 15 , p. 301-309 9 p.

Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane

Engel M.F.M., Khemtemourian L.P., Kleijer C.C., Meeldijk J.D., Jacobs J., Verkleij A.J., de Kruijff B., Killian J.A., Hoppener J.W.M. 2008, In: Proceedings of the National Academy of Sciences of the United States of America. 105 , p. 6033-6038 6 p.

Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.

van Veelen W., van Gasteren C.J.R., Acton D.S., franklin D.S., Berger R., Lips C.J.M., Hoppener J.W.M. 2008, In: Cancer Research. 68 , p. 1329-1337 9 p.

Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in β-cell death in type II diabetes mellitus

Khemtémourian L.P., Killian J.A., Höppener J.W.M., Engel M.F.M. 2008, In: Experimental Diabetes Research. 2008 , p. 421287/1-421287/9 9 p.

Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus.

Höppener J.W.M., Jacobs H.M., Wierup N., Sotthewes G., Sprong M.G.H., de Vos P., Berger R., Sundler F., Ahrén B. 2008, In: Experimental Diabetes Research. 2008 , p. 697035 1 p.

Designing antibodies for the inhibition of gastrin activity in tumoral cell lines.

Barderas R., Shochat S., Timmerman P., Hollestelle M.J., Martinez-Torrecuadrada J.L., Hoppener J.W.M., Altschuh D., Meloen R., Casal J.I. 2008, In: International Journal of Cancer. 122 , p. 2351-2359 9 p.

Multiple Endocrine Neoplasia syndrome type 1 (MEN 1).

Lips C.J.M., Dreijerink K.M.A., Valk G.D., Höppener J.W.M. 2008, p. 177-185 9 p.

A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma.

Gujral TS, van Veelen W., Richardson D.S., Myers S.M., Meens J.A., Acton D.S., Dunach M, Elliott B.E., Höppener J.W.M., Mulligan L.M. 2008, In: Cancer Research. 68 , p. 1338-1346 9 p.

Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis

Joshi P.P., Kulkarni M.V., Yu B.K., Smith K.R., Norton D.L., van Veelen W., Hoppener J.W.M., franklin D.S. 2007, In: Oncogene. 26 , p. 554-570 17 p.

A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C.

Schreinemakers J.M.J., Zonnenberg B.A., Höppener J.W.M., Hes F.J., Borel Rinkes I.H.M., Lips C.J.M. 2007, In: World Journal of Surgical Oncology [E]. 5 , p. 112-112 1 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not